Biogen Inc. (BIIB) Competitors & Peers
The 5 largest companies in the same industry as Biogen Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| LLY | Peer | $1,152.93 | P/E 38.8RSI 47Cap 1.03 T |
| JNJ | Peer | $269.99 | P/E 31.3RSI 55Cap 650.6 B |
| ABBV | Peer | $263.96 | P/E 74.6RSI 59Cap 466.4 B |
| MRK | Peer | $146.87 | P/E 117.5RSI 57Cap 362.4 B |
| AZN | Peer | $166.08 | P/E 24.9RSI 55Cap 257.6 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- DNLIPartner
Biogen partners with Denali to co-develop LRRK2 inhibitors for Parkinson's disease treatment.
Model-inferred, unverified — treat as a lead, not evidence - TGTXCompetitor
Competes in multiple sclerosis treatment markets, where Biogen operates Ocrevus.
Model-inferred, unverified — treat as a lead, not evidence